HC Wainwright Reiterates Buy Rating for Actinium Pharmaceuticals (NYSE:ATNM)
Actinium Pharmaceuticals (NYSE:ATNM – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a report issued on Tuesday,Benzinga reports. They presently have a $4.00 price target on the stock. HC Wainwright’s price target would indicate a potential upside of 142.42% from the stock’s current price. Separately, Wall Street […]
Actinium Pharmaceuticals (NYSE:ATNM – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a report issued on Tuesday,Benzinga reports. They presently have a $4.00 price target on the stock. HC Wainwright’s price target would indicate a potential upside of 142.42% from the stock’s current price. Separately, Wall Street […]
